Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

COPD: Management Using Bronchodilators and Corticosteroids

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...

COPD: Pathogenesis and Clinical Features

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

British Thoracic Society quality standard for pulmonary rehabilitation.

BMJ open respiratory research·2026

Same author

Effect of Dietary Nitrate Supplementation on Exercise Performance in Hypoxic IPF (EDEN-OX3): a double-blind, placebo-controlled, randomised crossover study.

Thorax·2026

Same author

Relationship of breathlessness with social isolation and loneliness: a nationally representative cohort study of older adults in England.

BMJ public health·2026

Same author

Perceived Acceptability of SPACE for COPD© as a Maintenance Option Following Pulmonary Rehabilitation Discharge: A Qualitative Interview Study with Patients and Facilitators Using Framework Analysis.

International journal of chronic obstructive pulmonary disease·2026

Same author

The minimal important deterioration of the incremental shuttle walk test in chronic obstructive pulmonary disease: a prospective cohort study.

Annals of the American Thoracic Society·2026

Same author

Has the time come for workplace screening for obstructive sleep apnoea (OSA)?

Thorax·2026

Search research articles

Related Experiment Video

Updated: May 2, 2026

Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies

Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies

Published on: February 2, 2024

Minimum clinically important difference for the COPD Assessment Test: a prospective analysis.

Samantha S C Kon¹, Jane L Canavan¹, Sarah E Jones¹

¹NIHR Respiratory Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust, London, UK; Imperial College, London, UK.

The Lancet. Respiratory Medicine

|March 14, 2014

Summary

This summary is machine-generated.

The COPD Assessment Test (CAT) minimum clinically important difference (MCID) was established as 2 points. This finding aids in interpreting CAT scores for chronic obstructive pulmonary disease (COPD) patient outcomes.

More Related Videos

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography

Published on: July 10, 2018

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

Related Experiment Videos

Last Updated: May 2, 2026

Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies

Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies

Published on: February 2, 2024

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography

Published on: July 10, 2018

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

Area of Science:

Pulmonary Medicine
Clinical Trials
Health Outcomes Research

Background:

The COPD Assessment Test (CAT) is a validated tool for assessing chronic obstructive pulmonary disease (COPD) impact.
Establishing the minimum clinically important difference (MCID) for the CAT is crucial for interpreting patient-reported outcomes.
Previous research has not definitively established the MCID for the CAT.

Purpose of the Study:

To determine the minimum clinically important difference (MCID) for the COPD Assessment Test (CAT).
To utilize both anchor-based and distribution-based methods for MCID estimation.
To provide a reliable metric for clinical interpretation of CAT scores in COPD patients.

Main Methods:

Conducted three studies in London between 2010-2012 involving COPD patients undergoing pulmonary rehabilitation, hospitalization for exacerbation, or in stable outpatient settings.
Assessed changes in CAT scores alongside concurrent measurements of the St George's Respiratory Questionnaire (SGRQ) and Chronic Respiratory Questionnaire (CRQ) as anchors.
Employed receiver operating characteristic curves, linear regression, and distribution-based methods (half SD, SE of measurement) to estimate the MCID.

Main Results:

Pulmonary rehabilitation led to a mean CAT score change of -2.5, correlating with SGRQ and CRQ changes.
Hospitalized patients showed a mean CAT score change of -3.0 from discharge to 3 months, correlating with SGRQ.
Linear regression suggested an MCID range of -1.2 to -2.8, while ROC curves consistently identified -2 as the MCID. Distribution-based estimates ranged from -3.3 to -3.8.

Conclusions:

The most reliable estimate for the minimum important difference of the CAT is 2 points.
This 2-point MCID provides a valuable tool for clinical interpretation of CAT results.
The findings are particularly relevant for evaluating the effectiveness of interventions in COPD management.